Login to Your Account

Washington Roundup

Drugmaker Sues FDA Over Regs that 'Chill' Truthful Speech

By Mari Serebrov

Monday, October 24, 2011
WASHINGTON – When it comes to violations of the Federal Food, Drug and Cosmetic Act (FDCA), it's usually the FDA going after a drugmaker. But Par Pharmaceutical Inc. has turned the tables on the agency, saying the FDA is violating the FDCA and the First Amendment by restricting truthful speech about approved uses of Par's Megace ES.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription